OncoMD Lite
OncoMD Advanced

OncoMD is brought to the end user as an Enterprise solution and as a web-based plug in

For Researchers

Customized Research Solutions

Learn More

For Clinicians

Actionable Clinical Report

Learn More
  • 1.9+ million cancer mutations
  • 7,000+ peer reviewed publications
  • 17,000+ exome studies
  • 650,000+ samples

OncoMD helps to infer the impact of genomic alterations on cancer development

MedGenome Inc. is a genomics-based research company headquartered in California with the mission to improve global health by decoding genetic information contained in an individual's genome. It is also a founding member of GenomeAsia 100K initiative to sequence 100,000 Genomes in South, North and East Asia.

Our NGS lab in Foster City, California is ISO 15189 compliant, CLIA certified, and CAP accredited.

Let’s fight cancer together
oncomd@medgenome.com | (203) 823-6510